Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Sonja Vliek , Agnes Jager , Mojca Jonge-Lavrencic , Jean-Pierre Lotz , Anthony Goncalves (1, 2) , Monika Graeser , Ulrike Nitz , Ingrid A. M. Mandjes , Marjo J. Holtkamp , Margaret Schot , Valesca P. Retel , Evelien J. Kuip , Machteld N. Wymenga , Inge R. Konings , Vivianne C. G. Tjan-Heijnen , Judith R. Kroep , Der Carolien P. Schr , Elsken van Der Wall , Sabine C. Linn

1 Institut Paoli-Calmettes
2 CRCM - Centre de Recherche en Cancérologie de Marseille

Domains: Life Sciences [q-bio]

Sonja Vliek, Agnes Jager, Mojca Jonge-Lavrencic, Jean-Pierre Lotz, Anthony Goncalves, et al.. Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial. Cancer Research, 2018, 78 (4, S). ⟨hal-02143680⟩